content_top
43 companies, 1 interpreter! Insight, foresight
and recommendation 

MiMedx Group, Inc (MDXG)

14.34
0.10
(0.70%)
Sep 11, 4:00PM EDT
content_middle

MiMedx Group, Inc., together with its subsidiaries, operates as an integrated developer, manufacturer, and marketer of patent protected regenerative biomaterial products and allografts processed from human amniotic membranes. Its biomaterial platform technologies include HydroFix and CollaFix device technologies; and AmnioFix and EpiFix tissue technologies. Its tissue technologies, processed from the human amniotic membrane, utilize its proprietary Purion process to produce minimally manipulated implants. The company supplies amniotic tissues to distributors and original equipment manufacturers for application in the surgical, ophthalmic, orthopedics, spine, wound care, and dental sectors of healthcare. MiMedx Group sells its products directly, as well as through a network of third party sales agents and stocking distributors in the United States and internationally. The company is headquartered in Kennesaw, Georgia.

Previous Close: 
14.24
Open: 
14.35
Bid: 
14.25
Ask: 
15.20
1yr Target Price: 
15.14
Day's Range: 
14.23 - 14.90
52wk Range: 
7.64 - 17.47
Volume: 
2432303
Average Daily Volume: 
1482280
Market Capitalization: 
1.54B
Trailing Annual Dividend Yield: 
N/A
Shares Outstanding: 
107280000M
content_right

Pages